BofA analyst Pavan Patel lowered the firm’s price target on Amphastar (AMPH) to $30 from $31 and keeps a Neutral rating on the shares as the analyst took over coverage of the stock. While the firm views the stock as undervalued on comps and historical valuation, it remains cautious on pipeline execution risk, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPH: